Drug-related morbidity and mortality and the economic impact of pharmaceutical care - PubMed (original) (raw)

. 1997 Mar 1;54(5):554-8.

doi: 10.1093/ajhp/54.5.554.

Affiliations

• PMID: 9066865
• DOI: 10.1093/ajhp/54.5.554

Drug-related morbidity and mortality and the economic impact of pharmaceutical care

J A Johnson et al. Am J Health Syst Pharm. 1997.

No abstract available

PubMed Disclaimer

Similar articles

• Costs of drug-related morbidity and mortality: enormous and growing rapidly.
  Bates DW. Bates DW. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):156-7. doi: 10.1016/s1086-5802(16)31242-6. J Am Pharm Assoc (Wash). 2001. PMID: 11297325 No abstract available.
• Drug-related morbidity and mortality: updating the cost-of-illness model.
  Ernst FR, Grizzle AJ. Ernst FR, et al. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9. doi: 10.1016/s1086-5802(16)31229-3. J Am Pharm Assoc (Wash). 2001. PMID: 11297331
• Drug therapy: the impact of managed care.
  Hopkins J, Siu S, Cawley M, Rudd P. Hopkins J, et al. Adv Pharmacol. 1998;44:1-32. doi: 10.1016/s1054-3589(08)60124-6. Adv Pharmacol. 1998. PMID: 9547883 Review. No abstract available.
• Cost-effectiveness of consultant pharmacists in managing drug-related morbidity and mortality at nursing facilities.
  Harrison DL, Bootman JL, Cox ER. Harrison DL, et al. Am J Health Syst Pharm. 1998 Aug 1;55(15):1588-94. doi: 10.1093/ajhp/55.15.1588. Am J Health Syst Pharm. 1998. PMID: 9706185 No abstract available.
• Drug-related problems and pharmaceutical care: what are they, do they matter, and what's next?
  Hanlon JT, Artz MB. Hanlon JT, et al. Med Care. 2001 Feb;39(2):109-12. doi: 10.1097/00005650-200102000-00001. Med Care. 2001. PMID: 11176548 Review. No abstract available.

Cited by

• Modelling drug-related morbidity in Sweden using an expert panel of physicians.
  Hakkarainen KM, Alström D, Hägg S, Carlsten A, Gyllensten H. Hakkarainen KM, et al. Eur J Clin Pharmacol. 2012 Sep;68(9):1309-19. doi: 10.1007/s00228-012-1244-3. Epub 2012 Mar 6. Eur J Clin Pharmacol. 2012. PMID: 22392557
• Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand.
  Sungsana W, Nakaranurack C, Weeraphon B, Charoenwaiyachet W, Chanprasert S, Torvorapanit P, Santimaleeworagun W, Putcharoen O. Sungsana W, et al. J Pharm Policy Pract. 2023 Feb 24;16(1):29. doi: 10.1186/s40545-023-00538-z. J Pharm Policy Pract. 2023. PMID: 36829248 Free PMC article.
• Physicians' perception of CPOE implementation.
  Allenet B, Bedouch P, Bourget S, Baudrant M, Foroni L, Calop J, Bosson JL. Allenet B, et al. Int J Clin Pharm. 2011 Aug;33(4):656-64. doi: 10.1007/s11096-011-9521-2. Epub 2011 May 13. Int J Clin Pharm. 2011. PMID: 21567278
• A review of the pharmacoeconomics of pharmaceutical care.
  Plumridge RJ, Wojnar-Horton RE. Plumridge RJ, et al. Pharmacoeconomics. 1998 Aug;14(2):175-89. doi: 10.2165/00019053-199814020-00006. Pharmacoeconomics. 1998. PMID: 10186458 Review.
• The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.
  Lauschke VM, Ingelman-Sundberg M. Lauschke VM, et al. Int J Mol Sci. 2016 Oct 12;17(10):1714. doi: 10.3390/ijms17101714. Int J Mol Sci. 2016. PMID: 27754327 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information